FierceBiotech ١٥ ديسمبر ٢٠٢٥ Kyverna gains clear view to first CAR-T approval for autoimmune disease after 'truly remarkable' SPS readout
FierceBiotech ١٥ ديسمبر ٢٠٢٥ Beyond the ADC Hype: Innovation is accelerating through bispecifics and dual payload strategies
FierceBiotech ١٣ ديسمبر ٢٠٢٥ GAO probe finds understaffed FDA putting some medical device recall work on the 'back burner'
FierceBiotech ١٢ ديسمبر ٢٠٢٥ Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’
FierceBiotech ١٢ ديسمبر ٢٠٢٥ Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share
FierceBiotech ١٢ ديسمبر ٢٠٢٥ 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says
FierceBiotech ١٢ ديسمبر ٢٠٢٥ Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)
FierceBiotech ١١ ديسمبر ٢٠٢٥ Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
FierceBiotech ١١ ديسمبر ٢٠٢٥ Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
FierceBiotech ١١ ديسمبر ٢٠٢٥ Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test
FierceBiotech ١١ ديسمبر ٢٠٢٥ FDA clears Lumosity brain training games as a prescription app for adult ADHD
FierceBiotech ١١ ديسمبر ٢٠٢٥ Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech